Galmed Pharmaceuticals Ltd.
GLMD
|
|
| |
|
| Trading Volume | 2,257 |
|
|
0.87 - 0.26 |
| Market Cap Full | $ 6.8M |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | 9% | -29% | -14.6% | -12.6% |
| Q2 | - | 16.7% | 581.5% | -59.1% |
| Q3 | - | -12.9% | -78.7% | -52.2% |
| Q4 | - | 0.3% | -14.2% | 60.8% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 9 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| -18 | 6.7 | -18.8 | 14.9 | - | - | - | -12.9 | - | - | - | 8 |
| 2023 | |||||||||||
| 32 | -27.3 | -11 | -27.4 | 1387.1 | -36.9 | -60.5 | -29.7 | -23.4 | -37.9 | -7.8 | 28.2 |
| 2022 | |||||||||||
| -11 | -11.1 | 10.4 | 4.4 | -69.2 | 27 | -22.8 | -9.8 | -31.4 | 22.2 | -23.2 | 71.2 |
| 2021 | |||||||||||
| 19.6 | 6.7 | -15.4 | -3 | -18.7 | 14.7 | -16.9 | 29.5 | -14.7 | -12.3 | 3 | -27.8 |
| 2020 | |||||||||||
| -8.8 | -21.5 | -17.8 | 26 | 8.9 | 0.6 | 1.5 | 0.6 | -27.7 | -11.9 | 27.8 | -21.8 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | -1.1 | -0.2 | -0.4 | -0.3 |
| Q2 | -1 | -0.2 | -0.3 | -0.3 |
| Q3 | -0.2 | -0.2 | -0.3 | -0.3 |
| Q4 | 0 | -1.7 | -0.3 | -0.5 |
| A | -2.28 | -0.7 | -1.3 | -1.35 |